Jeffrey Elliott appointed to Quanterix board; brings Exact Sciences experience

Quanterix Corp

Appointed effective August 19, 2024 as a Class I director with term expiring at 2027 annual meeting.
Mr. Elliott served as CFO of Exact Sciences (2016-2024) and COO (2021-2023), scaling operations and overseeing acquisitions.
Received initial equity award valued at $400,000: 60% stock options and 40% RSUs, vesting over three years.
CEO Masoud Toloue cited Elliott's experience in scaling Alzheimer's disease testing infrastructure as valuable.
No family relationships or material transactions requiring disclosure under Item 404(a).

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jeffrey T. Elliott

Director

QTRX · Quanterix Corp

Effective: 2024-08-19
Filed: August 21, 2024, 7:59 PM ET

On August 19, 2024, the board of directors (the “Board”) of Quanterix Corporation (the “Company”) appointed Jeffrey T. Elliott to serve on the Board effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Jeffrey T. Elliott was appointed as Director at Quanterix Corp.

Action: appointed
Role: Director

Exact text from the filing

On August 19, 2024, the board of directors (the “Board”) of Quanterix Corporation (the “Company”) appointed Jeffrey T. Elliott to serve on the Board effective immediately.

View on SEC.gov

Quanterix Corp filing history →

Source: SEC EDGAR

accession 0001628280-24-038023

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.